Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$619M |
| 2 |
Citigroup
C
|
+$457M |
| 3 |
Cimpress
CMPR
|
+$379M |
| 4 |
Broadcom
AVGO
|
+$374M |
| 5 |
Apple
AAPL
|
+$287M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$348M |
| 2 |
Microsoft
MSFT
|
+$331M |
| 3 |
IQVIA
IQV
|
+$243M |
| 4 |
Costco
COST
|
+$193M |
| 5 |
St. Joe Company
JOE
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.21% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.77% |
| 4 | Industrials | 12.77% |
| 5 | Consumer Discretionary | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RHT
326
DELISTED
Red Hat Inc
RHT
| $116M | 0.07% |
1,045,639
-53,021
| -5% | -$5.43M |
|
327
Incyte
INCY
$23.5B
| $116M | 0.07% |
991,198
-54,165
| -5% | -$6.85M |
|
|
TSRO
328
DELISTED
TESARO, Inc.
TSRO
| $116M | 0.07% |
895,556
+178,406
| +25% | +$22.1M |
|
329
Cintas
CTAS
$82.4B
| $115M | 0.07% |
3,186,736
-1,266,380
| -28% | -$42.2M |
|
|
SFR
330
DELISTED
Starwood Waypoint Homes
SFR
| $115M | 0.07% |
3,156,690
-665,715
| -17% | -$23.8M |
|
|
NVRO
331
DELISTED
NEVRO CORP.
NVRO
| $114M | 0.07% |
1,249,367
-172,600
| -12% | -$14.8M |
|
332
H.B. Fuller
FUL
$3B
| $113M | 0.07% |
1,950,986
-121,251
| -6% | -$6.34M |
|
333
AutoZone
AZO
$48.3B
| $113M | 0.07% |
190,119
-3,960
| -2% | -$2.11M |
|
334
Arch Capital
ACGL
$36.1B
| $113M | 0.07% |
3,431,034
+206,238
| +6% | +$6.65M |
|
|
FNGN
335
DELISTED
Financial Engines, Inc.
FNGN
| $112M | 0.07% |
3,235,665
+313,400
| +11% | +$10.9M |
|
336
AvalonBay Communities
AVB
$27.1B
| $112M | 0.07% |
629,410
+378,809
| +151% | +$71M |
|
|
FOLD
337
DELISTED
Amicus Therapeutics
FOLD
| $112M | 0.07% |
7,434,314
+407,304
| +6% | +$5.39M |
|
338
Eversource Energy
ES
$28.2B
| $112M | 0.07% |
1,854,043
+1,087,774
| +142% | +$67.1M |
|
339
PG&E
PCG
$47.8B
| $111M | 0.07% |
1,632,420
+49,927
| +3% | +$3.42M |
|
340
Icon
ICLR
$12.8B
| $111M | 0.07% |
974,043
-94,116
| -9% | -$10M |
|
341
Glaukos
GKOS
$9.02B
| $110M | 0.07% |
3,344,361
+225,105
| +7% | +$8.55M |
|
342
Arthur J. Gallagher & Co
AJG
$63.7B
| $110M | 0.07% |
1,786,242
-66,702
| -4% | -$3.92M |
|
343
Workday
WDAY
$33.4B
| $110M | 0.07% |
1,042,200
+4,047
| +0.4% | +$418K |
|
344
Williams Companies
WMB
$90.5B
| $109M | 0.07% |
3,637,582
-1,184,682
| -25% | -$36M |
|
|
ETFC
345
DELISTED
E*Trade Financial Corporation
ETFC
| $109M | 0.07% |
2,494,035
+1,031,749
| +71% | +$41.9M |
|
346
Canadian Pacific Kansas City
CP
$82B
| $108M | 0.07% |
3,212,165
-162,875
| -5% | -$5.18M |
|
|
EGRX
347
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $108M | 0.07% |
1,807,202
-22,997
| -1% | -$1.39M |
|
348
Outfront Media
OUT
$5.64B
| $108M | 0.07% |
4,344,094
-68,873
| -2% | -$1.52M |
|
|
DCP
349
DELISTED
DCP Midstream, LP
DCP
| $106M | 0.07% |
3,067,318
-1,246
| -0% | -$41K |
|
350
Tyson Foods
TSN
$20.2B
| $105M | 0.07% |
1,487,580
-991,362
| -40% | -$63.4M |
|
Similar funds
Janus Henderson Group's Q3 2017 Portfolio in Review
As of Q3 2017, Janus Henderson Group held 1,386 positions worth $156B, up 5.9% from $147B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Janus Henderson Group's Q3 2017 filing shows 78 new, 598 increased, 569 reduced and 102 closed positions. Its largest new stake was Medtronic: 7,457,362 shares worth $580M. The largest sale was Reynolds American Inc, an estimated $348M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2017 buy was Medtronic: 7,457,362 shares worth $580M.
- Janus Henderson Group added most to Citigroup in Q3 2017, an estimated $457M increase.
- Janus Henderson Group's biggest Q3 2017 reduction was Microsoft, cutting an estimated $331M.
- Janus Henderson Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $348M.
- Janus Henderson Group's ten largest holdings make up 14% of its $156B portfolio in Q3 2017.
- Janus Henderson Group opened 78 new positions and closed 102 in Q3 2017.
- Janus Henderson Group's portfolio value rose 5.9% quarter-over-quarter to $156B.
Based on Janus Henderson Group's 13F filing for Q3 2017, filed 14 Nov 2017.